Press Release
NARAL Pro-Choice America Responds to Fifth Circuit Decision on Alliance for Hippocratic Medicine v. FDA
WASHINGTON, DC – Today, the U.S. Fifth Circuit Court of Appeals issued a ruling in Alliance for Hippocratic Medicine v. FDA. While the status of medication abortion access remains unchanged for now, the fight for medication abortion is far from over.
NARAL Pro-Choice America President Mini Timmaraju released the following statement in response:
“The bottom line is that this decision does not change the availability of mifepristone today or in the immediate future. Despite the attempts by rightwing judges and politicians, medication abortion remains available. It is a safe and effective option for abortion care that has been used by millions of people for decades. As this baseless lawsuit makes its way to an extremist Supreme Court, we will continue to fight with our allies to protect and expand access to medication abortion for all.”
In response to the Alliance for Hippocratic Medicine v. FDA ruling blocking the FDA approval of mifepristone, NARAL Pro-Choice America and partners across the progressive movement launched the People’s Petition to mobilize against lower courts’ baseless rulings and fight to protect reproductive freedom for all.
###
For over 50 years, NARAL Pro-Choice America has fought to protect and advance reproductive freedom at the federal and state levels—including access to abortion care, birth control, pregnancy and post-partum care, and paid family leave—for everybody. NARAL is powered by its 4 million members from every state and congressional district in the country, representing the 8 in 10 Americans who support legal abortion.